Cargando…
Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway
BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the bl...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533599/ https://www.ncbi.nlm.nih.gov/pubmed/36199030 http://dx.doi.org/10.1186/s12879-022-07752-1 |
_version_ | 1784802379302961152 |
---|---|
author | Zou, Peicen Yang, Fan Ding, Yijun Zhang, Di Liu, Ying Zhang, Jinjing Wu, Dan Wang, Yajuan |
author_facet | Zou, Peicen Yang, Fan Ding, Yijun Zhang, Di Liu, Ying Zhang, Jinjing Wu, Dan Wang, Yajuan |
author_sort | Zou, Peicen |
collection | PubMed |
description | BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the blood-brain barrier (BBB), leading to intracranial inflammation. However, the specific mechanism of bacterial meningitis induced by LPS damaging BBB remains unclear. In this study, the mouse brain microvascular endothelial (bEND.3) cells were used as a research object to investigate whether LPS damage BBB through the PI3K/Akt pathway. METHODS: The bEND.3 cells were stimulated with different concentrations of LPS for 12 h, and the expression of tight junction proteins (ZO-1, claudin-5, occludin) was detected using western blotting. The cells were challenged with the same concentration of LPS (1ug/ml) across different timepoints (0, 2 h, 4 h, 6 h, 12 h, 24 h). Expression of TJ proteins and signal pathway molecules (PI3K, p-PI3K, Akt, p-Akt) were detected. The distribution of ZO-1 in bEND.3 cells were detected by immunofluorescence staining. RESULTS: A negative correlation is observed between ZO-1 and LPS concentration. Moreover, a reduced expression of ZO-1 was most significant under 1 ug/ml of LPS, and the difference was statistically significant (P < 0.05). Additionally, there is a negative correlation between ZO-1 and LPS stimulation time. Meanwhile, the expression of claudin-5 and occludin did not change significantly with the stimulation of LPS concentration and time. The immunofluorescence assay showed that the amount of ZO-1 on the surface of bEND.3 cells stimulated with LPS was significantly lower than that of the control group. After LPS stimulation, p-Akt protein increased at 2 h and peaked at 4 h. The titer of p-PI3K did not change significantly with time. CONCLUSION: LPS can downregulate the expression of ZO-1; however, its effect on claudin-5 and occludin is minimal. Akt signal pathway may be involved in the regulation of ZO-1 expression induced by LPS in bEND.3 cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07752-1. |
format | Online Article Text |
id | pubmed-9533599 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95335992022-10-06 Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway Zou, Peicen Yang, Fan Ding, Yijun Zhang, Di Liu, Ying Zhang, Jinjing Wu, Dan Wang, Yajuan BMC Infect Dis Research BACKGROUND: Neonatal bacterial meningitis is a common neonatal disease with high morbidity, and can cause serious sequelae when left untreated. Escherichia coli is the common pathogen, and its endotoxin, lipopolysaccharide (LPS) can damage the endothelial cells, increasing the permeability of the blood-brain barrier (BBB), leading to intracranial inflammation. However, the specific mechanism of bacterial meningitis induced by LPS damaging BBB remains unclear. In this study, the mouse brain microvascular endothelial (bEND.3) cells were used as a research object to investigate whether LPS damage BBB through the PI3K/Akt pathway. METHODS: The bEND.3 cells were stimulated with different concentrations of LPS for 12 h, and the expression of tight junction proteins (ZO-1, claudin-5, occludin) was detected using western blotting. The cells were challenged with the same concentration of LPS (1ug/ml) across different timepoints (0, 2 h, 4 h, 6 h, 12 h, 24 h). Expression of TJ proteins and signal pathway molecules (PI3K, p-PI3K, Akt, p-Akt) were detected. The distribution of ZO-1 in bEND.3 cells were detected by immunofluorescence staining. RESULTS: A negative correlation is observed between ZO-1 and LPS concentration. Moreover, a reduced expression of ZO-1 was most significant under 1 ug/ml of LPS, and the difference was statistically significant (P < 0.05). Additionally, there is a negative correlation between ZO-1 and LPS stimulation time. Meanwhile, the expression of claudin-5 and occludin did not change significantly with the stimulation of LPS concentration and time. The immunofluorescence assay showed that the amount of ZO-1 on the surface of bEND.3 cells stimulated with LPS was significantly lower than that of the control group. After LPS stimulation, p-Akt protein increased at 2 h and peaked at 4 h. The titer of p-PI3K did not change significantly with time. CONCLUSION: LPS can downregulate the expression of ZO-1; however, its effect on claudin-5 and occludin is minimal. Akt signal pathway may be involved in the regulation of ZO-1 expression induced by LPS in bEND.3 cells. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-022-07752-1. BioMed Central 2022-10-05 /pmc/articles/PMC9533599/ /pubmed/36199030 http://dx.doi.org/10.1186/s12879-022-07752-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zou, Peicen Yang, Fan Ding, Yijun Zhang, Di Liu, Ying Zhang, Jinjing Wu, Dan Wang, Yajuan Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title | Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title_full | Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title_fullStr | Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title_full_unstemmed | Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title_short | Lipopolysaccharide downregulates the expression of ZO-1 protein through the Akt pathway |
title_sort | lipopolysaccharide downregulates the expression of zo-1 protein through the akt pathway |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533599/ https://www.ncbi.nlm.nih.gov/pubmed/36199030 http://dx.doi.org/10.1186/s12879-022-07752-1 |
work_keys_str_mv | AT zoupeicen lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT yangfan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT dingyijun lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT zhangdi lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT liuying lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT zhangjinjing lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT wudan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway AT wangyajuan lipopolysaccharidedownregulatestheexpressionofzo1proteinthroughtheaktpathway |